itraconazole has been researched along with Candidiasis in 22 studies
Candidiasis: Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fluconazole (FLC) is the drug of choice when it comes to treat fungal infections such as invasive candidiasis in humans." | 3.85 | Novel alkylated azoles as potent antifungals. ( Garneau-Tsodikova, S; Garzan, A; Shrestha, SK, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (13.64) | 18.2507 |
| 2000's | 10 (45.45) | 29.6817 |
| 2010's | 5 (22.73) | 24.3611 |
| 2020's | 4 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Bartroli, J | 3 |
| Turmo, E | 3 |
| Algueró, M | 3 |
| Boncompte, E | 3 |
| Vericat, ML | 3 |
| García-Rafanell, J | 3 |
| Forn, J | 3 |
| Conte, L | 2 |
| Ramis, J | 2 |
| Merlos, M | 2 |
| Ohwada, J | 1 |
| Tsukazaki, M | 1 |
| Hayase, T | 1 |
| Oikawa, N | 1 |
| Isshiki, Y | 1 |
| Fukuda, H | 1 |
| Mizuguchi, E | 1 |
| Sakaitani, M | 1 |
| Shiratori, Y | 1 |
| Yamazaki, T | 1 |
| Ichihara, S | 1 |
| Umeda, I | 1 |
| Shimma, N | 1 |
| Vandeputte, P | 1 |
| Tronchin, G | 1 |
| Bergès, T | 1 |
| Hennequin, C | 1 |
| Chabasse, D | 1 |
| Bouchara, JP | 1 |
| Yao, B | 1 |
| Ji, H | 1 |
| Cao, Y | 1 |
| Zhou, Y | 1 |
| Zhu, J | 1 |
| Lü, J | 1 |
| Li, Y | 1 |
| Chen, J | 1 |
| Zheng, C | 1 |
| Jiang, Y | 1 |
| Liang, R | 1 |
| Tang, H | 1 |
| Fritsche, TR | 1 |
| Rhomberg, PR | 1 |
| Sader, HS | 1 |
| Jones, RN | 1 |
| Gomez-Lopez, A | 1 |
| Alastruey-Izquierdo, A | 1 |
| Rodriguez, D | 1 |
| Almirante, B | 1 |
| Pahissa, A | 1 |
| Rodriguez-Tudela, JL | 1 |
| Cuenca-Estrella, M | 1 |
| Garcia-Effron, G | 2 |
| Kontoyiannis, DP | 1 |
| Lewis, RE | 1 |
| Perlin, DS | 2 |
| Lamping, E | 1 |
| Ranchod, A | 1 |
| Nakamura, K | 1 |
| Tyndall, JD | 1 |
| Niimi, K | 1 |
| Holmes, AR | 1 |
| Niimi, M | 1 |
| Cannon, RD | 1 |
| Arendrup, MC | 1 |
| Buzina, W | 1 |
| Mortensen, KL | 1 |
| Reiter, N | 1 |
| Lundin, C | 1 |
| Jensen, HE | 1 |
| Lass-Flörl, C | 1 |
| Bruun, B | 1 |
| Dimopoulos, G | 1 |
| Velegraki, A | 1 |
| Falagas, ME | 1 |
| Mann, PA | 1 |
| McNicholas, PM | 1 |
| Chau, AS | 1 |
| Patel, R | 1 |
| Mendrick, C | 1 |
| Ullmann, AJ | 1 |
| Cornely, OA | 1 |
| Patino, H | 1 |
| Black, TA | 1 |
| MacCallum, DM | 1 |
| Coste, A | 1 |
| Ischer, F | 1 |
| Jacobsen, MD | 1 |
| Odds, FC | 1 |
| Sanglard, D | 1 |
| Miyazaki, T | 1 |
| Yamauchi, S | 1 |
| Inamine, T | 1 |
| Nagayoshi, Y | 1 |
| Saijo, T | 1 |
| Izumikawa, K | 1 |
| Seki, M | 1 |
| Kakeya, H | 1 |
| Yamamoto, Y | 1 |
| Yanagihara, K | 1 |
| Miyazaki, Y | 1 |
| Kohno, S | 1 |
| Shrestha, SK | 1 |
| Garzan, A | 1 |
| Garneau-Tsodikova, S | 1 |
| Lino, CI | 1 |
| Gonçalves de Souza, I | 1 |
| Borelli, BM | 1 |
| Silvério Matos, TT | 1 |
| Santos Teixeira, IN | 1 |
| Ramos, JP | 1 |
| Maria de Souza Fagundes, E | 1 |
| de Oliveira Fernandes, P | 1 |
| Maltarollo, VG | 1 |
| Johann, S | 1 |
| de Oliveira, RB | 1 |
| Emami, S | 1 |
| Ghobadi, E | 1 |
| Saednia, S | 1 |
| Hashemi, SM | 1 |
| Montoir, D | 1 |
| Guillon, R | 1 |
| Gazzola, S | 1 |
| Ourliac-Garnier, I | 1 |
| Soklou, KE | 1 |
| Tonnerre, A | 1 |
| Picot, C | 1 |
| Planchat, A | 1 |
| Pagniez, F | 1 |
| Le Pape, P | 1 |
| Logé, C | 1 |
| Han, G | 1 |
| Liu, N | 1 |
| Li, C | 1 |
| Tu, J | 1 |
| Li, Z | 1 |
| Sheng, C | 1 |
| Radakovic, N | 1 |
| Nikolić, A | 1 |
| Jovanović, NT | 1 |
| Stojković, P | 1 |
| Stankovic, N | 1 |
| Šolaja, B | 1 |
| Opsenica, I | 1 |
| Pavic, A | 1 |
| Zhang, X | 1 |
| Wang, M | 1 |
| Zhu, X | 1 |
| Peng, Y | 1 |
| Fu, T | 1 |
| Hu, CH | 1 |
| Cai, J | 1 |
| Liao, G | 1 |
1 review available for itraconazole and Candidiasis
| Article | Year |
|---|---|
Current advances of triazole alcohols derived from fluconazole: Design, in vitro and in silico studies.
Topics: Animals; Antifungal Agents; Candida; Candidiasis; Drug Design; Drug Discovery; Fluconazole; Fungi; H | 2019 |
1 trial available for itraconazole and Candidiasis
| Article | Year |
|---|---|
Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis | 2009 |
20 other studies available for itraconazole and Candidiasis
| Article | Year |
|---|---|
Synthesis and antifungal activity of new azole derivatives containing an N-acylmorpholine ring.
Topics: Animals; Antifungal Agents; Azoles; Candidiasis; Female; Male; Mice; Microbial Sensitivity Tests; Ra | 1995 |
New azole antifungals. 2. Synthesis and antifungal activity of heterocyclecarboxamide derivatives of 3-amino-2-aryl-1-azolyl-2-butanol.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Colony Count, Microbi | 1998 |
New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Colony Count, Microbi | 1998 |
Design, synthesis and antifungal activity of a novel water soluble prodrug of antifungal triazole.
Topics: Animals; Antifungal Agents; Aspergillosis; Biotransformation; Candidiasis; Chemical Phenomena; Chemi | 2003 |
Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; DNA Primers; Genes, Fungal; Genetic Complementatio | 2007 |
Synthesis and antifungal activities of novel 2-aminotetralin derivatives.
Topics: Administration, Intravaginal; Animals; Antifungal Agents; Binding Sites; Candida albicans; Candidias | 2007 |
Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections.
Topics: Antifungal Agents; Antimicrobial Cationic Peptides; Aspergillosis; Aspergillus; Candida; Candidiasis | 2008 |
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain.
Topics: Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Microbial Sensitivity Tests; Population S | 2008 |
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida tropicalis; Candidiasis; Caspofungin; Drug Resis | 2008 |
Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Blotting | 2009 |
Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Cas | 2009 |
A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece.
Topics: Antifungal Agents; Candida; Candidiasis; Data Collection; Disease Susceptibility; Greece; Humans; In | 2009 |
Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection.
Topics: Animals; Antifungal Agents; Base Sequence; Candida albicans; Candidiasis; Disease Models, Animal; DN | 2010 |
Roles of calcineurin and Crz1 in antifungal susceptibility and virulence of Candida glabrata.
Topics: Animals; Antifungal Agents; Base Sequence; Calcineurin; Candida glabrata; Candidiasis; DNA Primers; | 2010 |
Novel alkylated azoles as potent antifungals.
Topics: Alkylation; Animals; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Cell Line; Ergosterol | 2017 |
Synthesis, molecular modeling studies and evaluation of antifungal activity of a novel series of thiazole derivatives.
Topics: Antifungal Agents; Candida; Candidiasis; Cryptococcosis; Cryptococcus; HEK293 Cells; Humans; Microbi | 2018 |
New azole antifungals with a fused triazinone scaffold.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Mice; Microbial | 2020 |
Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis.
Topics: 14-alpha Demethylase Inhibitors; Animals; Azoles; Candida albicans; Candidiasis; Cytochrome P450 Fam | 2020 |
Unraveling the anti-virulence potential and antifungal efficacy of 5-aminotetrazoles using the zebrafish model of disseminated candidiasis.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Humans; Tetrazoles; Virulence; Zebrafish | 2022 |
Development of Lipo-γ-AA Peptides as Potent Antifungal Agents.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fluconazole; Mic | 2022 |